Covidien PLC (COV.N)
63.57USD
4:01pm EDT
$-2.37 (-3.59%)
$65.94
$65.88
$65.89
$63.55
851,256
711,568
$68.82
$50.40
COV.N
About
Overall
Financials
| COV.N | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 72.70 | 30.65 |
| EPS (TTM): | -- | -- | -- |
| ROI: | -- | 4.63 | 18.83 |
| ROE: | -- | 9.75 | 19.74 |
Covidien to acquire CV Ingenuity
- Medical device and products maker Covidien Plc on Wednesday said it has a definitive agreement to acquire CV Ingenuity, a privately-held company focusing on treatments for peripheral arterial disease.
Earnings vs. 
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Datamonitor
|
$175.00
|
|
Provider: Market Edge
|
$10.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$115.00
|
|
Provider: Pechala's Reports
|
$15.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
